Life Science & Pharma IP Litigation 2023
Wikborg Rein is a contributing firm to the Life Science & Pharma IP Litigation 2023 with Chambers and Partners.
Our commentary provides expert insights on life science and pharma intellectual property litigation in Norway, relevant for everyone working within these sectors or with IP litigation in general. The chapter is written by our IP litigation experts Lars Erik Steinkjer, Nora Bratheim and Guro S. Kyrkjebø Nybø.
You can read the full guide here or the Norwegian chapter from page 95